Insider at JCI (NYSE: JCI) files Form 144 to sell 21,595 shares
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
JCI reported a planned Rule 144 sale of 21,595 ordinary shares through Morgan Stanley Smith Barney LLC on the NYSE, with an approximate sale date of 12/10/2025. The filing lists an aggregate market value of about 2,504,940.10 for these shares and notes that 611,135,665 shares of the same class were outstanding. The shares to be sold come from restricted stock vesting under a registered plan, with 14,608 shares acquired on 12/05/2025, 1,549 shares on 12/08/2025, and 5,438 shares on 12/06/2024, all as compensation for services rendered.
Positive
- None.
Negative
- None.
FAQ
What does JCI's Form 144 filing disclose?
The Form 144 for JCI discloses a planned sale of 21,595 ordinary shares on the NYSE under Rule 144, using Morgan Stanley Smith Barney LLC as broker.